Bushra Shahida
Bushra Shahida
Department of Clinical Sciences, Genomics, Diabetes and Endocrinology, Lund University, Malmö, Sweden
Department of Diabetes & Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by Bushra Shahida in
Google Scholar
PubMed
Department of Diabetes & Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by Bushra Shahida in
Google Scholar
PubMed
Tereza Planck
Tereza Planck
Department of Clinical Sciences, Genomics, Diabetes and Endocrinology, Lund University, Malmö, Sweden
Department of Diabetes & Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by Tereza Planck in
Google Scholar
PubMed
Department of Diabetes & Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by Tereza Planck in
Google Scholar
PubMed
Tania Singh
Tania Singh
Department of Clinical Sciences, Genomics, Diabetes and Endocrinology, Lund University, Malmö, Sweden
Search for other papers by Tania Singh in
Google Scholar
PubMed
Search for other papers by Tania Singh in
Google Scholar
PubMed
Peter Åsman
Peter Åsman
Department of Clinical Sciences Malmö, Ophthalmology, Lund University, Malmö, Sweden
Department of Ophthalmology, Skåne University Hospital, Malmö, Sweden
Search for other papers by Peter Åsman in
Google Scholar
PubMed
Department of Ophthalmology, Skåne University Hospital, Malmö, Sweden
Search for other papers by Peter Åsman in
Google Scholar
PubMed
Mikael Lantz
Mikael Lantz
Department of Clinical Sciences, Genomics, Diabetes and Endocrinology, Lund University, Malmö, Sweden
Department of Diabetes & Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by Mikael Lantz in
Google Scholar
PubMed
Department of Diabetes & Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by Mikael Lantz in
Google Scholar
PubMed
were downregulated by diclofenac. Simvastatin is known for its immunomodulatory and anti-inflammatory effects; however, the precise molecular mechanisms underlying these effects are not fully known ( 29 ). Statins are used as lipid-lowering drugs
Ling Sun
Ling Sun
Department of Cardiology, The Affiliated Changzhou No.2 People’s Hospital of Nanjing Medical University, Changzhou, Jiangsu, China
Section of Pacing and Electrophysiology, Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Search for other papers by Ling Sun in
Google Scholar
PubMed
Section of Pacing and Electrophysiology, Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Search for other papers by Ling Sun in
Google Scholar
PubMed
Wenwu Zhu
Wenwu Zhu
Department of Cardiology, Xuzhou Central Hospital, Xuzhou Clinical School of Nanjing Medical University, Xuzhou, Jiangsu, China
Search for other papers by Wenwu Zhu in
Google Scholar
PubMed
Search for other papers by Wenwu Zhu in
Google Scholar
PubMed
Yuan Ji
Yuan Ji
Department of Cardiology, The Affiliated Changzhou No.2 People’s Hospital of Nanjing Medical University, Changzhou, Jiangsu, China
Search for other papers by Yuan Ji in
Google Scholar
PubMed
Search for other papers by Yuan Ji in
Google Scholar
PubMed
Ailin Zou
Ailin Zou
Department of Cardiology, The Affiliated Changzhou No.2 People’s Hospital of Nanjing Medical University, Changzhou, Jiangsu, China
Search for other papers by Ailin Zou in
Google Scholar
PubMed
Search for other papers by Ailin Zou in
Google Scholar
PubMed
Lipeng Mao
Lipeng Mao
Department of Cardiology, The Affiliated Changzhou No.2 People’s Hospital of Nanjing Medical University, Changzhou, Jiangsu, China
Dalian Medical University, Dalian, Liaoning, China
Search for other papers by Lipeng Mao in
Google Scholar
PubMed
Dalian Medical University, Dalian, Liaoning, China
Search for other papers by Lipeng Mao in
Google Scholar
PubMed
Boyu Chi
Boyu Chi
Department of Cardiology, The Affiliated Changzhou No.2 People’s Hospital of Nanjing Medical University, Changzhou, Jiangsu, China
Dalian Medical University, Dalian, Liaoning, China
Search for other papers by Boyu Chi in
Google Scholar
PubMed
Dalian Medical University, Dalian, Liaoning, China
Search for other papers by Boyu Chi in
Google Scholar
PubMed
Jianguang Jiang
Jianguang Jiang
Department of Cardiology, The Affiliated Changzhou No.2 People’s Hospital of Nanjing Medical University, Changzhou, Jiangsu, China
Search for other papers by Jianguang Jiang in
Google Scholar
PubMed
Search for other papers by Jianguang Jiang in
Google Scholar
PubMed
Xuejun Zhou
Xuejun Zhou
Department of Cardiology, The Affiliated Changzhou No.2 People’s Hospital of Nanjing Medical University, Changzhou, Jiangsu, China
Search for other papers by Xuejun Zhou in
Google Scholar
PubMed
Search for other papers by Xuejun Zhou in
Google Scholar
PubMed
Qingjie Wang
Qingjie Wang
Department of Cardiology, The Affiliated Changzhou No.2 People’s Hospital of Nanjing Medical University, Changzhou, Jiangsu, China
Search for other papers by Qingjie Wang in
Google Scholar
PubMed
Search for other papers by Qingjie Wang in
Google Scholar
PubMed
Fengxiang Zhang
Fengxiang Zhang
Section of Pacing and Electrophysiology, Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Search for other papers by Fengxiang Zhang in
Google Scholar
PubMed
Search for other papers by Fengxiang Zhang in
Google Scholar
PubMed
.783 β-blocker 738 (58.8%) 144 (64.3%) 0.12 438 (65.2%) 144 (64.3%) 0.872 Statins 1127 (89.7%) 195 (87.1%) 0.232 599 (89.1%) 195 (87.1%) 0.466 Low molecular heparin 1233 (98.2%) 216 (96.4%) 0.094 653 (97
